Proactive - Interviews for investors

HANetf co-CEO Hector McNeil talked with Proactive's Stephen Gunnion after bitcoin topped $100,000 as the a more crypto-friendly US administration sparked more buying of the cryptocurrency. McNeil predicted its price to reach $150,000 by mid-2024 due to increased participation from institutional and retail investors.

McNeil discussed other potential catalysts from the new administration in 2025, including impacts on the defence, oil, and gas sectors. He highlighted the uranium sector, emphasising its constrained supply and rising demand, suggesting HANetf’s Sprott Uranium Miners ETF and the Sprott Junior Uranium Miners UCITS (LSE:URJP) as valuable options.

McNeil also mentioned opportunities in rebuilding Ukraine’s defence infrastructure, likening it to “Israel on steroids.” He detailed how HANetf’s products like the Alerian Midstream Energy Dividend UCITS ETF (LSE:MMLP) and Future of Defence UCITS ETF (LSE:NATO) stand to benefit from these developments.

Visit Proactive's YouTube channel for more videos, and don't forget to give this video a like, subscribe to the channel, and enable notifications for future content.

#HANetf #HectorMcNeil #UraniumInvesting #BitcoinPrice #ETFs #DefenseStocks #TrumpTrade #OilAndGas #CryptoInvestment #NuclearEnergy #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

EMV Capital (AIM:EMVC) CEO Dr Ilian Iliev talked with Proactive about the company's recent oversubscribed capital raise of £1.5 million, highlighting the strong support from shareholders and retail investors. Iliev discussed the challenging market conditions and the company's ability to attract investment at a 15% premium to market price.

He explained that EMV Capital plans to utilise the funds to expand its fund management practice, support its Venture Build program, and target £200 million in assets under management (AUM). Notable achievements include the creation of £7 million in value across four companies with modest investments.

Iliev also outlined the company’s diversified business model, with over 70 portfolio companies and a proven value-creation strategy. He emphasised the company's route to breakeven, aided by operational income and expected portfolio company exits in the next 18-24 months.

"2025 will be an absolutely exciting year for us," Iliev noted.

Discover more about EMV Capital's strategic vision and investment potential by watching the full interview on Proactive's YouTube channel. Don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#EMVCapital #Investment #VentureCapital #TechInvesting #LifeSciences #Fundraising #BusinessGrowth #ProactiveInvestors #DeepTech #FinancialMarkets #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Light Science Technologies Holdings PLC (AIM:LST) CEO Simon Deacon speaks with Proactive's Stephen Gunnion about the company's c.30% revenue growth, profitability milestones, and innovations driving margin expansion.

Deacon highlighted growth across all divisions for the 12 months ended 30 November, particularly the Controlled Environment Agriculture (CEA) segment, which saw a 250% increase. He attributed profitability improvements to efficiency gains and the high-margin nature of products in the passive fire protection and CEA segments. Deacon noted that the group's pipeline for CEA projects now exceeds £50 million, with significant contributions from environmental sensors and light recipe technology.

Looking ahead, Deacon discussed plans for global expansion, focusing on markets in the Americas, the Middle East, and Australia, facilitated by partnerships. Despite the discontinuation of a product line by a long-term pest control client, Deacon expressed confidence in the company's cash runway and its ability to sustain growth into 2025.

"We've really turned the corner," he said, adding that the company is positioned for balanced growth across its divisions.

For more insights from this conversation, visit Proactive's YouTube channel, give this video a like, subscribe to the channel, and enable notifications for future updates.

#LightScienceTechnologies #RevenueGrowth #EnvironmentalSensors #PassiveFireProtection #ControlledEnvironmentAgriculture #SustainableTech #GlobalExpansion #InnovativeSolutions #ProactiveInvestors #Profitability #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Proactive’s Tylah Tully gives a ‘Small Caps Wrap’ - an overview of the strongest performers in the small-cap sector for the week ending Friday, December 6.

Cyprium Metals Ltd was among the top performers in the small caps sector, gaining 70% to $0.029 per share before settling at $0.026.

The company announced its Board of Directors had rejected an indicative non-binding offer (NBIO) from Appian Capital Advisory to acquire Cyprium at $0.035 per share, citing it as not in the best interests of shareholders.

Lumos Diagnostics Ltd recorded a weekly high of $0.043, up 48%.

Polymetals Resources Ltd reached a record $0.965 cents, a 46.7% rise, now at $0.90, following updates on its Endeavor Mine redevelopment.

Recruitment plans aim to scale the workforce from six to 230 by next year.

European Lithium Ltd rose 44%, Yandal Resources reached $0.30, and Orthocell climbed 31% to $1.13.

Aldoro Resources Ltd saw exceptional growth, surging 186% from $0.089 to $0.255, driven by midweek assay results confirming significant niobium mineralisation on Line 4 with a 0.52% average grade.

AuMega Metals Ltd moved upwards by 24.33% to reach $0.046, Silver Mines Ltd was up by 18.56% to $0.115 and Imugene Ltd hit $0.0435, up by 17.57%.

#ProactiveInvestors #SmallCaps #ASX #SmallCapWrap #CypriumMetals #LumosDiagnostics #PolymetalsResources #EuropeanLithium #YandalResources #Orthocell #AldoroResources #MiningUpdates #StockMarket #NiftyCopperComplex #PatersonRegion #EndeavorMine #Niobium #MineralExploration #SharePrice #StockPerformance #Investing #MarketUpdate #AustralianStocks

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) executive co-chair and acting CEO Mike Spreadborough talked with Proactive’s Tylah Tully about the company’s recent sale of 38% of its holding in San Cristobal for $11.5 million.

Spreadborough highlighted the liquidity this sale provides and its role in securing upcoming exploration plans for 2025.

Spreadborough noted, “It's a really good chunk of cash,” further emphasising that the sale value exceeded its current book valuation.

He also reassured stakeholders that the remaining 60% holding in San Cristobal continues to be a significant and strategic asset.

He went on to discuss Northern Star Resources’ $5 billion acquisition of De Grey Mining.

With Novo Resources holding a joint venture agreement with De Grey, Spreadborough viewed this development positively, underlining its implications for Novo’s tenements near the Hemi gold plant site.

This interview offers insights into Novo Resources’ strategic initiatives and investment plans.

#ProactiveInvestors #NovoResources #ASX #TSXNVO #OTCQXNSRPF #ASXNVO #MiningInvestment #GoldExploration #SanCristobal #DeGreyMining #NorthernStarResources #GoldMiningNews

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Nova Minerals Ltd (ASX:NVA, NASDAQ:NVA).

The company has identified a significant antimony-rich zone at the Stibium prospect within its Estelle Gold and Critical Minerals Project in Alaska. Reconnaissance rock chip samples recorded antimony grades as high as 56.7%, with 11 samples exceeding 30% antimony. The mineralised zone spans 800 by 400 metres and remains open for further exploration.

Antimony is a critical mineral with applications in defence and advanced technologies, including night vision, explosives, and nuclear weapons. Due to China’s export restrictions on antimony, Nova is engaging with the US Department of Defense and seeking grant funding to expedite project development. The company is also a member of the Defense Industrial Base Consortium to enhance government-industry collaboration.

The Stibium prospect has been prioritised as a high-grade, drill-ready target. Nova anticipates results from 2024 gold exploration, with prior gold grades reaching up to 12.7 g/t. The Estelle Project also includes the RPM gold deposit and the Korbel bulk tonnage deposit.

Key sampling highlights include 56.7%, 55.7%, and 54.8% antimony. The company has made significant progress in its grant funding applications to further its resource development efforts.

#ProactiveInvestors #NovaMinerals, #ASX #NASDAQ #JusttheFacts #Antimony, #CriticalMinerals, #GoldExploration, #StibiumProspect, #EstelleProject, #MiningUpdates, #USDefense, #HighGradeDiscovery, #FutureTech, #ResourceDevelopment, #GeologicalSurvey, #GoldResults, #RPMDeposit, #KorbelDeposit, #MiningInnovation, #AlaskaMining, #MineralExploration, #SupplyChainSecurity, #GrantFunding

Alterity Therapeutics (ASX:ATH) CEO Dr. David Stamler talked with Proactive’s Tylah Tully about the company’s advancements in therapies for neurodegenerative diseases, with a focus on multiple system atrophy (MSA).

Dr. Stamler outlined the unique mechanism of action of their lead drug, which targets excess iron in the brain to address neurodegeneration.

He emphasised the importance of early intervention, highlighting results from the company’s open-label study, where 30% of late-stage MSA patients showed neurological improvement.

“What we showed is that in those patients that responded, they actually had stabilisation of biomarkers,” said Dr. Stamler.

Alterity anticipates data from its pivotal Phase 2 trial early next year, with plans to explore accelerated approval pathways or move into Phase 3 trials.

The potential market for the drug is significant, with over 15,000 MSA patients in the US alone, and projected peak sales exceeding $1 billion USD.

Dr. Stamler also shared insights into expanding the drug’s application to other conditions, including Parkinson’s disease and Friedrich’s ataxia.

#ProactiveInvestors #AlterityTherapeutics #ASX #MSATreatment #NeurodegenerativeDiseases #BiotechInnovation #HealthcareResearch #RareDiseases #ParkinsonianDisorders #FriedrichsAtaxia #ClinicalTrials

Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) managing director Tim Harrison talked with Proactive’s Tylah Tully about the company’s significant milestone of applying for a capital grant from the UK Government to fast-track a commercial battery recycling facility in Belfast.

Harrison called the application a "big milestone" for the team, adding that it could serve as a cornerstone investment to advance the project.

The Belfast facility feasibility study indicated a net present value of $500 million and a post-tax internal rate of return of 44%, with a capital cost of £85 million.

Harrison emphasised the project's long-term potential, noting its role in rare earth recycling.

"We’re bullish on the recycling opportunity and this facility positions us well for future growth," he said.

He also mentioned opportunities to expand the technology into markets like the US and Brazil.

Looking forward, the company anticipates hearing back on the grant application in early 2025, with plans to finalise financing for the project in the first half of the year.

With strong support from UK stakeholders, Ionic Rare Earths is optimistic about its ability to capitalise on growing demand for critical raw materials and energy transition solutions.

#ProactiveInvestors #IonicRareEarths #ASX #RareEarths #ASXIXR #RecyclingSolutions #CriticalMinerals #BelfastFacility #RareEarthOxides #ProactiveUpdates

Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO and managing director Daniel Tillett talks with Proactive’s Tylah Tully about the company’s recent achievements, including submitting an ethics approval application for its Phase 1 RC220 clinical trial.

He explained the importance of this milestone, as it marks the kickoff of a clinical program for a newly reformulated cancer drug.

Tillett elaborated on the drug’s history, noting how past challenges were resolved by reformulating it to eliminate previous obstacles.

He highlighted its dual potential to combat cancer effectively and protect the cardiovascular system from chemotherapy-induced damage.

"The results of that can be life-changing," Tillett remarked, emphasising the transformative potential for patient outcomes.

Reflecting on 2024, Tillett noted the company’s success in manufacturing the drug to GMP standards, completing GLP safety studies and setting up the framework for clinical trials.

Looking ahead, he outlined goals for 2025, including demonstrating the drug’s safety and proving its cardiovascular protection capabilities in clinical trials.

#ProactiveInvestors #RaceOncology #ASX #RAC #OTCRAONF #RC220 #ClinicalTrials #CancerResearch #DrugDevelopment #MedicalInnovation #CardiovascularHealth #OncologyNews #ProactiveUpdates

Greatland Gold PLC (AIM:GGP, OTC:GRLGF) CEO Shaun Day spoke with Proactive’s Tylah Tully about the acquisition of the Telfer Mine and Havieron Project from Newmont.

This milestone marks a transformative moment for Greatland, as it transitions into a gold and copper producer with a strong development pipeline in Australia.

Shaun Day reflected on the acquisition's significance, stating, "We take 100% ownership of Telfer and Havieron, positioning us as a significant Australian gold-copper producer."

He shared insights from the first day on-site under Greatland’s ownership, highlighting a renewed focus on safety, exploration and long-term mine planning.

"Telfer isn’t lost in a global portfolio. This is our focus," Day emphasised.

Greatland aims to integrate production from Telfer’s open pit and underground mines with output from Havieron, creating a unified mine plan for the Telfer mill.

Additionally, the company plans to extend mine life, incorporate new resources and explore further regional opportunities.

Day described the breadth of opportunities as “exciting,” with plans to maximize reserves and maintain a long-term growth strategy.

#ProactiveInvestors #GreatlandGold #AIM #OTC #TelferMine #HavieronProject #GoldMining #CopperProduction #AIMGGP #AustralianMining #ProactiveUpdates